ID   LRRT2_RAT               Reviewed;         515 AA.
AC   D4A7P2;
DT   08-MAR-2011, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   24-JUL-2024, entry version 88.
DE   RecName: Full=Leucine-rich repeat transmembrane neuronal protein 2;
DE   AltName: Full=Leucine-rich repeat neuronal 2 protein;
DE   Flags: Precursor;
GN   Name=Lrrtm2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, INTERACTION WITH DLG4, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AND MUTAGENESIS OF 512-GLU--VAL-515.
RX   PubMed=19285470; DOI=10.1016/j.neuron.2009.01.017;
RA   Linhoff M.W., Lauren J., Cassidy R.M., Dobie F.A., Takahashi H.,
RA   Nygaard H.B., Airaksinen M.S., Strittmatter S.M., Craig A.M.;
RT   "An unbiased expression screen for synaptogenic proteins identifies the
RT   LRRTM protein family as synaptic organizers.";
RL   Neuron 61:734-749(2009).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH DLG4 AND NRXN1.
RX   PubMed=20064388; DOI=10.1016/j.neuron.2009.12.019;
RA   de Wit J., Sylwestrak E., O'Sullivan M.L., Otto S., Tiglio K., Savas J.N.,
RA   Yates J.R. III, Comoletti D., Taylor P., Ghosh A.;
RT   "LRRTM2 interacts with Neurexin1 and regulates excitatory synapse
RT   formation.";
RL   Neuron 64:799-806(2009).
RN   [4]
RP   FUNCTION, INTERACTION WITH NEUREXIN, AND MUTAGENESIS OF 157-ARG-LYS-158;
RP   ARG-181; LYS-206 AND ARG-208.
RX   PubMed=30100184; DOI=10.1016/j.cell.2018.07.002;
RA   Zhang P., Lu H., Peixoto R.T., Pines M.K., Ge Y., Oku S., Siddiqui T.J.,
RA   Xie Y., Wu W., Archer-Hartmann S., Yoshida K., Tanaka K.F., Aricescu A.R.,
RA   Azadi P., Gordon M.D., Sabatini B.L., Wong R.O.L., Craig A.M.;
RT   "Heparan Sulfate Organizes Neuronal Synapses through Neurexin
RT   Partnerships.";
RL   Cell 174:1450-1464(2018).
CC   -!- FUNCTION: Involved in the development and maintenance of excitatory
CC       synapses in the nervous system. Regulates surface expression of AMPA
CC       receptors and instructs the development of functional glutamate release
CC       sites. Acts as a ligand for the presynaptic receptors NRXN1-A and
CC       NRXN1-B. {ECO:0000269|PubMed:19285470, ECO:0000269|PubMed:20064388,
CC       ECO:0000269|PubMed:30100184}.
CC   -!- SUBUNIT: Interacts with DLG4 (PubMed:19285470, PubMed:20064388).
CC       Interacts with neurexin NRXN1; interaction is mediated by heparan
CC       sulfate glycan modification on neurexin (PubMed:20064388,
CC       PubMed:30100184). {ECO:0000269|PubMed:19285470,
CC       ECO:0000269|PubMed:20064388, ECO:0000269|PubMed:30100184}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Postsynaptic cell membrane; Single-pass type I membrane
CC       protein. Note=Localized to excitatory synapses.
CC   -!- TISSUE SPECIFICITY: Expressed in neuronal tissues. Widely distributed
CC       in neuropil regions in discrete puncta throughout the brain (at protein
CC       level). Detected in cortex, thalamus, striatum, olfactory bulb,
CC       cerebellum and all hippocampal subfields (at protein level). More
CC       abundant in deep than in superficial layers of neocortex (at protein
CC       level). {ECO:0000269|PubMed:19285470}.
CC   -!- DOMAIN: Synaptogenic effects are mediated by the extracellular LRR
CC       region.
CC   -!- SIMILARITY: Belongs to the LRRTM family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH473974; EDL76254.1; -; Genomic_DNA.
DR   RefSeq; NP_001102939.1; NM_001109469.1.
DR   AlphaFoldDB; D4A7P2; -.
DR   SMR; D4A7P2; -.
DR   STRING; 10116.ENSRNOP00000067172; -.
DR   GlyCosmos; D4A7P2; 4 sites, No reported glycans.
DR   GlyGen; D4A7P2; 4 sites.
DR   iPTMnet; D4A7P2; -.
DR   PhosphoSitePlus; D4A7P2; -.
DR   PaxDb; 10116-ENSRNOP00000067172; -.
DR   ABCD; D4A7P2; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000075420.3; ENSRNOP00000067172.2; ENSRNOG00000047085.3.
DR   Ensembl; ENSRNOT00055039707; ENSRNOP00055032244; ENSRNOG00055023116.
DR   Ensembl; ENSRNOT00060045986; ENSRNOP00060038179; ENSRNOG00060026552.
DR   Ensembl; ENSRNOT00065020507; ENSRNOP00065015760; ENSRNOG00065012607.
DR   GeneID; 685472; -.
DR   KEGG; rno:685472; -.
DR   UCSC; RGD:1593785; rat.
DR   AGR; RGD:1593785; -.
DR   CTD; 26045; -.
DR   RGD; 1593785; Lrrtm2.
DR   eggNOG; KOG0619; Eukaryota.
DR   GeneTree; ENSGT00940000160581; -.
DR   HOGENOM; CLU_032965_0_0_1; -.
DR   InParanoid; D4A7P2; -.
DR   OMA; DMWQSLG; -.
DR   OrthoDB; 2875365at2759; -.
DR   PhylomeDB; D4A7P2; -.
DR   TreeFam; TF332659; -.
DR   Reactome; R-RNO-6794361; Neurexins and neuroligins.
DR   PRO; PR:D4A7P2; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   Proteomes; UP000234681; Chromosome 18.
DR   Bgee; ENSRNOG00000047085; Expressed in brain and 4 other cell types or tissues.
DR   GO; GO:0060076; C:excitatory synapse; IDA:MGI.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; IDA:SynGO.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0042043; F:neurexin family protein binding; IPI:BHF-UCL.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0002091; P:negative regulation of receptor internalization; ISO:RGD.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0099151; P:regulation of postsynaptic density assembly; IDA:SynGO.
DR   GO; GO:0050808; P:synapse organization; IDA:MGI.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1.
DR   InterPro; IPR050328; Dev_Immune_Receptor.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   PANTHER; PTHR24373:SF268; LEUCINE RICH REPEAT TRANSMEMBRANE NEURONAL 2; 1.
DR   PANTHER; PTHR24373; SLIT RELATED LEUCINE-RICH REPEAT NEURONAL PROTEIN; 1.
DR   Pfam; PF13855; LRR_8; 3.
DR   PRINTS; PR00019; LEURICHRPT.
DR   SMART; SM00369; LRR_TYP; 9.
DR   SUPFAM; SSF52058; L domain-like; 1.
DR   PROSITE; PS51450; LRR; 10.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycoprotein; Leucine-rich repeat; Membrane;
KW   Postsynaptic cell membrane; Reference proteome; Repeat; Signal; Synapse;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..33
FT                   /evidence="ECO:0000255"
FT   CHAIN           34..515
FT                   /note="Leucine-rich repeat transmembrane neuronal protein
FT                   2"
FT                   /id="PRO_0000405434"
FT   TOPO_DOM        34..421
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        422..442
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        443..515
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          61..83
FT                   /note="LRR 1"
FT   REPEAT          84..107
FT                   /note="LRR 2"
FT   REPEAT          109..131
FT                   /note="LRR 3"
FT   REPEAT          132..155
FT                   /note="LRR 4"
FT   REPEAT          156..179
FT                   /note="LRR 5"
FT   REPEAT          181..203
FT                   /note="LRR 6"
FT   REPEAT          205..227
FT                   /note="LRR 7"
FT   REPEAT          229..251
FT                   /note="LRR 8"
FT   REPEAT          252..275
FT                   /note="LRR 9"
FT   REPEAT          276..299
FT                   /note="LRR 10"
FT   MOTIF           512..515
FT                   /note="Involved in DLG4-binding"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        126
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        243
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        362
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         157..158
FT                   /note="RK->AA: Reduced heparan sulfate binding and reduced
FT                   induction of presynaptic differentiation; when associated
FT                   with A-181, A-206 and A-208."
FT                   /evidence="ECO:0000269|PubMed:30100184"
FT   MUTAGEN         181
FT                   /note="R->A: Reduced heparan sulfate binding and reduced
FT                   induction of presynaptic differentiation; when associated
FT                   with 157-A-A-158, A-206 and A-208."
FT                   /evidence="ECO:0000269|PubMed:30100184"
FT   MUTAGEN         206
FT                   /note="K->A: Reduced heparan sulfate binding and reduced
FT                   induction of presynaptic differentiation; when associated
FT                   with 157-A-A-158, A-181 and A-208."
FT                   /evidence="ECO:0000269|PubMed:30100184"
FT   MUTAGEN         208
FT                   /note="R->A: Reduced heparan sulfate binding and reduced
FT                   induction of presynaptic differentiation; when associated
FT                   with 157-A-A-158; A-181 and A-206."
FT                   /evidence="ECO:0000269|PubMed:30100184"
FT   MUTAGEN         512..515
FT                   /note="Missing: Loss of DLG4-binding."
FT                   /evidence="ECO:0000269|PubMed:19285470"
SQ   SEQUENCE   515 AA;  58804 MW;  DA8E14ACE61F7714 CRC64;
     MGLHFKWPLG APMLAAIYAM SVVLKMLPAL GMACPPKCRC EKLLFYCDSQ GFHSVPNATD
     KGSLGLSLRH NHITALERDQ FASFSQLTWL HLDHNQISTV KEDAFQGLYK LKELILSSNK
     IFYLPNTTFT QLINLQNLDL SFNQLSSLHP ELFYGLRKLQ TLHLRSNSLR TIPVRLFWDC
     RSLEFLDLST NRLRSLARNG FAGLIKLREL HLEHNQLTKI NFAHFLRLSS LHTLFLQWNK
     ISNLTCGMEW TWSTLEKLDL TGNEIKAIDL TVFETMPNLK ILLMDNNKLN SLDSKILSSL
     RSLTTVGLSG NLWECSPRVC ALASWLGSFQ GRWEHSILCH SPDHTQGEDI LDAVHGFQLC
     WNLSTTVTAM ATTYRDPTTE YTKISSSSYH VGDKEIPTTA GIAVTTEEHF PEPDNAIFTQ
     RVITGTMALL FSFFFIIFIV FISRKCCPPT LRRIRQCSMI QNHRQLRSQT RLHMSNMSDQ
     GPYSEYEPTH EGPFIIINGY GQCKCQQLPY KECEV
//
